Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Yangtze River Pharmaceutical is a key subsidiary of the Yangtze River Pharmaceutical Group (YRPG), one of China's largest and most prominent pharmaceutical conglomerates. The company focuses on the research, development, and large-scale manufacturing of a wide range of pharmaceutical products, including chemical generics and Traditional Chinese Medicines (TCM). Its portfolio covers diverse therapeutic areas such as cardiovascular health, gastroenterology, and anti-infectives. Anhui Yangtze River Pharmaceutical operates advanced manufacturing facilities that adhere to stringent Good Manufacturing Practice (GMP) standards to supply both domestic and international markets. The company plays a vital role in YRPG's broader strategy of integrating modern pharmaceutical science with traditional herbal medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Yangtze River Pharmaceutical.